跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Rosvastium - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Rosvastium
Approved
STANDARD
Rosvastium
Rhydburg Pharmaceuticals Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
3736580f2517ba74
Company
Rhydburg Pharmaceuticals Ltd.
Type
Standard
Approval Details
Approval Id
3736580f2517ba74
Drug Approval Philippines Name
Rosvastium
Product Name
Rosvastium
Registration Number
DRP-7037-01
Brand Name
Rosvastium
Generic Name
Rosuvastatin (As Calcium)
Dosage Form
Film-Coated Tablet
Dosage Strength
10 mg
Manufacturer
Rhydburg Pharmaceuticals Ltd.
Importer
Ambica International Corporation
Distributor
Ambicare Pharmaceuticals Inc.
Issuance Date
27 April 2021
Expiry Date
10 February 2026
Pharmacologic Category
HMG CoA reductase inhibitor
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
3736580f2517ba74
Type
Standard
Back to Philippines FDA Approvals